Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Production process
Production process
Closed Production
Products 41 to 50 of 174
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
BioXp 3200: Benchtop DNA Assembly
by
SGI-DNA
+
Synthetic Genomics
Biotech components:
N/A
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
+
Research
Date added:
2018/08/30 11:49 (5 years ago)
Date last modified:
2018/09/19 16:02 (5 years ago)
Known funding amount:
40,000,000 USD
Funding types:
Venture Capital
Industry:
Science
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Design
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Platform
Blue Rose
by
Taxa
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (5 years ago)
Date last modified:
2018/10/02 11:47 (5 years ago)
Known funding amount:
909,000 USD
Funding types:
Crowdfunding
+
Private Funding
Industry:
Novelty
Market status:
No longer on the market
Organization type(s):
Private Company
Product categories:
Plant
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Finished Product
BSG005 for Systemic Fungal Infections
by
Biosergen ES
Biotech components:
Bacteria
Business models:
B2B
Country of production:
Norway
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (5 years ago)
Date last modified:
2018/08/30 11:49 (5 years ago)
Known funding amount:
N/A
Funding types:
Venture Capital
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Butamax Bio-Isobutanol
by
Butamax
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (5 years ago)
Date last modified:
2018/10/02 15:45 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Cadnano
by
Autodesk
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (5 years ago)
Date last modified:
2019/01/30 12:03 (4 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Science
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Design
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
ADSK
(NASDAQ)
Value chain stage:
Platform
Caffeinated Apple
by
Taxa
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (5 years ago)
Date last modified:
2018/08/30 11:49 (5 years ago)
Known funding amount:
909,000 USD
Funding types:
Crowdfunding
+
Private Funding
Industry:
Food & Agriculture
Market status:
No longer on the market
Organization type(s):
Private Company
Product categories:
Plant
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Cellic CTec
by
Novozymes
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Denmark
Country of distribution:
USA
+
Italy
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (5 years ago)
Date last modified:
2018/08/30 11:49 (5 years ago)
Known funding amount:
29,300,000 USD
Funding types:
Shareholder Investment
+
Government
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
NZYM-B
(CPH)
Value chain stage:
Input
Cellular Implant for Detection of Hypercalcemia Associated with Cancer
by
ETH Zurich
Biotech components:
Gene Editing
Business models:
B2C
Country of production:
Switzerland
Country of distribution:
Switzerland
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (5 years ago)
Date last modified:
2018/10/08 14:47 (5 years ago)
Known funding amount:
N/A
Funding types:
Government
Industry:
Health
Market status:
Early Stage Concept
Organization type(s):
Research Institution
+
University
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Cellulosic Ethanol
by
Qteros
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (5 years ago)
Date last modified:
2018/09/28 16:56 (5 years ago)
Known funding amount:
54,000,000 USD
Funding types:
Venture Capital
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Clearwood (TM) Patchouli Oil
by
Amyris
+
Firmenich
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
+
Switzerland
Country of distribution:
Switzerland
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (5 years ago)
Date last modified:
2019/02/15 12:43 (4 years ago)
Known funding amount:
471,900,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Personal Care (Topical)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
AMRS
(NASDAQ)
Value chain stage:
Finished Product
1
2
3
4
5
6
7
8
9
10
…
18
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
